Cidara Therapeutics Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

This study tests the safety of giving repeated annual doses of an experimental drug called CD388 to healthy adults. About 400 people who already tolerated one dose without serious side effects will receive two more doses over two years. Researchers will monitor for side effects a…

This study tests whether giving a high-dose flu vaccine together with a new long-acting antiviral drug, CD388, is safe and does not weaken the body's immune response. About 100 healthy adults aged 18 to 49 will receive either the vaccine plus CD388 or the vaccine plus a placebo. …